(Q44396648)

English

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

scientific article published on 2 April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

United States of America

0 references

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

antimicrobial resistance

1 reference

based on heuristic

inferred from title

Clyde Thornsberry

2

object named as

Clyde Thornsberry

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

object named as

Daniel F Sahm

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

James A Karlowsky

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mark E Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Alan T Evangelista

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ian A Critchley

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

TRUST Surveillance Program

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

2 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

963-970

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999).

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Streptococcus pneumoniae: bacteremia in an era of penicillin resistance

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

In vitro pharmacodynamic modelling simulating free serum concentrations of fluoroquinolones against multidrug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000.

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory se

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Prevention of neural-tube defects

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Expanding uses of fluoroquinolones: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1086%2F374052

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44396648&oldid=1940506323"